Abstract
Radiation-induced sarcoma in the head and neck (RISHN) is a rare condition whose clinical presentation and management remain difficult because of its low incidence. In this retrospective study, we analyzed the symptoms, diagnosis, and the treatment of 16,634 patients with head and neck disease, who received radiotherapy between 1960 and 2010 at the Affiliated Tumor Hospital and its predecessor, Guangxi Medical University, China. Among these patients, 16 with a first tumor of nasopharyngeal carcinoma (NPC) and 1 with squamous carcinoma of the tongue met the criteria of RISHN in the head and neck. Our epidemiological data showed that the incidence of RISHN rose from 0.06 to 0.17% from 1960 to 2010; the 3-year overall survival rate was 19.1%, and 3-year disease-free survival rate was 11.1%. The mean latency (SD) period was 93.2 (33) months. Based on the experiences at our institution, we suggest that RISHN is a rare complication after radiotherapy for head and neck tumors, especially NPC. Owing to its low incidence, it should not be a major factor affecting decisions about radiotherapy. Nevertheless, there may be a possibility of increasing incidence of RISHN after radiotherapy of NPC, as shown in our epidemiological results. Given the poor prognosis of RISHN, this possibility should be taken into serious consideration before determination of high-dose radiotherapy for patients with NPC and other head and neck tumors.
Similar content being viewed by others
References
Ravichandran R. Has the time come for doing away with cobalt-60 teletherapy for cancer treatments. J Med Phys. 2009;34(2):63–5.
Holt GE, Thomson AB, Griffin AM, et al. Multifocality and multifocal postradiation sarcomas. Clin Orthop Relat Res. 2006;450:67–75.
Mark RJ, Bailet JW, Poen J, et al. Postirradiation sarcoma of the head and neck. Cancer. 1993;72(3):887–93.
Maghami EG, St-John M, Bhuta S, Abemayor E. Postirradiation sarcoma: a case report and current review. Am J Otolaryngol. 2005;26(1):71–4.
Devi BC, Pisani P, Tang TS, Parkin DM. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev. 2004;13(3):482–6.
Cancer incidence in five continents: vol V, vol 88. IARC Science Publication; 1987. p. 1–970.
Li JY, Liu BQ, Li GY, Chen ZJ, Sun XI, Rong SD. Atlas of cancer mortality in the People’s Republic of China. An aid for cancer control and research. Int J Epidemiol. 1981;10(2):127–33.
Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case–control study in Guangxi, China. Cancer Res. 1988;48(7):1954–9.
Lin JC, Jan JS. Locally advanced nasopharyngeal cancer: long-term outcomes of radiation therapy. Radiology. 1999;211(2):513–8.
Patel SG, See AC, Williamson PA, Archer DJ, Evans PH. Radiation induced sarcoma of the head and neck. Head Neck. 1999;21(4):346–54.
Mark RJ, Poen J, Tran LM, Fu YS, Selch MT, Parker RG. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994;73(10):2653–62.
Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone: report of 11 cases. Cancer. 1948;1(1):3–29.
Murray EM, Werner D, Greeff EA, Taylor DA. Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys. 1999;45(4):951–61.
King AD, Ahuja AT, Teo P, Tse GM, Kew J. Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol. 2000;55(9):684–9.
Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64(1):47–56.
Faulkner K, Moores BM. Radiation dose and somatic risk from computed tomography. Acta Radiol. 1987;28(4):483–8.
Huda W. Is energy imparted a good measure of the radiation risk associated with CT examinations? Phys Med Biol. 1984;29(9):1137–42.
Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176(2):289–96.
Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation-related subsequent malignant tumors in survivors of Ewing’s sarcoma. J Natl Cancer Inst. 1979;62(6):1401–6.
Boivin JF, O’Brien K. Solid cancer risk after treatment of Hodgkin’s disease. Cancer. 1988;61(12):2541–6.
Fox C, Romeijn HE, Lynch B, Men C, Aleman DM, Dempsey JF. Comparative analysis of 60Co intensity-modulated radiation therapy. Phys Med Biol. 2008;53(12):3175–88.
Buchanan R. Cobalt on the way out. Br Med J (Clin Res Ed). 1986;292(6516):290.
Wiklund TA, Blomqvist CP, Raty J, Elomaa I, Rissanen P, Miettinen M. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer. 1991;68(3):524–31.
Seo IS, Warner TF, Warren JS, Bennett JE. Cutaneous postirradiation sarcoma. Ultrastructural evidence of pluripotential mesenchymal cell derivation. Cancer. 1985;56(4):761–7.
Amendola BE, Amendola MA, McClatchey KD, Miller CH Jr. Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol. 1989;12(5):411–5.
Laskin WB, Silverman TA, Enzinger FM. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer. 1988;62(11):2330–40.
Sale KA, Wallace DI, Girod DA, Tsue TT. Radiation-induced malignancy of the head and neck. Otolaryngol Head Neck Surg. 2004;131(5):643–5.
Miyahara H, Sato T, Yoshino K. Radiation-induced cancers of the head and neck region. Acta Otolaryngol Suppl. 1998;533:60–4.
van der Laan BF, Baris G, Gregor RT, Hilgers FJ, Balm AJ. Radiation-induced tumours of the head and neck. J Laryngol Otol. 1995;109(4):346–9.
Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.
Lee AW, Foo W, Mang O, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980–1999): an encouraging reduction in both incidence and mortality. Int J Cancer. 2003;103(5):680–5.
Ko JY, Chen CL, Lui LT, Hsu MM. Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122(5):535–8.
Afqir S, Ismaili N, Alaoui K, et al. Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients. Eur Arch Otorhinolaryngol. 2009;266(11):1767–73.
Ou SH, Zell JA, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007;18(1):29–35.
Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56(5):294–306.
Acknowledgments
This study was supported by the Guangxi Natural Science Foundation of China for Youth (No. 2010GXNSFB013067), the Special Foundation of the Key Laboratory of Early Prevention and Treatment for Regional High Incidence Tumor(0842009-Z12)and Guangxi Medical University Research Foundation for PhD (304193). The authors express their gratitude to the staff of the radiotherapy department of the Affiliated Tumor Hospital of Guangxi Medical University for excellent technical help and constructive criticism. We also thank Dr. Armando Chapin Rodriguez for his editing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y. Xie contributed equally.
Rights and permissions
About this article
Cite this article
Wei, Z., Xie, Y., Xu, J. et al. Radiation-induced sarcoma of head and neck: 50 years of experience at a single institution in an endemic area of nasopharyngeal carcinoma in China. Med Oncol 29, 670–676 (2012). https://doi.org/10.1007/s12032-011-9828-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-011-9828-9